| |
Latest 10 SEC filings (by transaction date) for KURA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 30/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -4,825 | $21.55 |
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -963 | $17.80 |
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -761 | $17.80 |
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -594 | $17.80 |
Jan 31/24 | Jan 29/24 | Bair Teresa Brophy | Direct Ownership | Common Stock | S - Open market or private sale | -2,053 | $17.80 |
Jan 31/24 | Jan 29/24 | Ford Kathleen | Direct Ownership | Common Stock | S - Open market or private sale | -1,496 | $17.80 |
Jan 31/24 | Jan 29/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -2,758 | $17.80 |
Jan 31/24 | Jan 29/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -4,400 | $17.80 |
Jan 26/24 | Jan 24/24 | Wilson Troy Edward | Direct Ownership | Common Stock | S - Open market or private sale | -84,107 | $20.23 |
Jan 26/24 | Jan 24/24 | Wilson Troy Edward | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 84,107 | $6.15 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for KURA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -963 | $17.80 |
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -761 | $17.80 |
Jan 31/24 | Jan 29/24 | Doyle Thomas James | Direct Ownership | Common Stock | S - Open market or private sale | -594 | $17.80 |
Jan 31/24 | Jan 29/24 | Bair Teresa Brophy | Direct Ownership | Common Stock | S - Open market or private sale | -2,053 | $17.80 |
Jan 31/24 | Jan 29/24 | Ford Kathleen | Direct Ownership | Common Stock | S - Open market or private sale | -1,496 | $17.80 |
Jan 31/24 | Jan 30/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -4,825 | $21.55 |
Jan 31/24 | Jan 29/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -2,758 | $17.80 |
Jan 31/24 | Jan 29/24 | Dale Stephen | Direct Ownership | Common Stock | S - Open market or private sale | -4,400 | $17.80 |
Jan 26/24 | Jan 24/24 | Wilson Troy Edward | Direct Ownership | Common Stock | S - Open market or private sale | -84,107 | $20.23 |
Jan 26/24 | Jan 24/24 | Wilson Troy Edward | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 84,107 | $6.15 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |